BioMarin Pharmaceutical Inc. Logs a Combined Blockbuster – Motley Fool


Motley Fool
BioMarin Pharmaceutical Inc. Logs a Combined Blockbuster
Motley Fool
BioMarin Pharmaceutical (NASDAQ:BMRN) logged over $1 billion in revenue — the traditional level for a blockbuster — for the first time in 2016. Of course, that’s combined sales of its four drugs, but it’s still a mighty accomplishment that many
BioMarin Pharmaceutical Breaks Below 200-Day Moving Average – Notable for BMRNNasdaq
Analyst Activity – Cowen and Company Reiterates Buy on BioMarin Pharmaceutical (NASDAQ:BMRN)Market Exclusive
BioMarin Pharmaceutical (BMRN) Q4 2016 Results – Earnings Call …Seeking Alpha
Equities.com -FX Daily Report -DailyQuint
all 32 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd